PA MedTech VC Fund
Pfäffikon, SwitzerlandFounded 2021
PA MedTech VC Fund is a venture capital fund managed by Swiss wealth manager Picard Angst, making direct equity investments in early-stage medical technology start-ups, primarily through the Shifamed innovation hub in Silicon Valley. The fund focuses on cardiology, ophthalmology, and e-health companies at Series A through Series C stages.
88% of their portfolio is in Healthcare. Their most common stage is series-b (50% of deals). Average disclosed round size is $45.4M (across 8 rounds with reported amounts).
Portfolio
8
Fund Size
$50M
Top Stage
Series B
Last 12 Mo
0
Team
PP
Peter Pilavachi
General Partner
CC
Christophe Constantin
Member of the Investment Committee
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
8 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Laza Medical | Series A | $36M | Dec 2023 |
 Akura Medical | Series B | $35M | Oct 2023 |
 Tioga Cardiovascular | Series C | $30M | Feb 2023 |
 Myra Vision | Series B | $25M | Jan 2023 |
 Adona Medical | Series B | $37.5M | Apr 2022 |
 Atia Vision | Series E | $42M | Jan 2022 |
| AAdona | Series B | $37.5M | Jan 2022 |
 Supira Medical | Series E | $120M | — |
Top Co-Investors
Cormorant Asset Management7 shared
The General Partnership4 shared
AMD Ventures3 shared
Northpond Ventures2 shared
Excelestar Ventures2 shared
Arena Holdings1 shared
Gilde Healthcare1 shared
LAV1 shared
415 Capital1 shared
Novo Capital1 shared
Qatar Investment Authority1 shared
Last updated: 27 September 2026